home . 2009 news
 

Recent News

     NuVision : NuVision NVU65FX5 65" LCD Flat-Panel HDTV

     Javelin Pharmaceutical : Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals

     Promia : Promia HawkTM Protects Home Banking

     NuVision : Home Theater Review 2009 Best of Awards

     Javelin Pharmaceutical : Dyloject(TM) New Drug Application to FDA for Management of Acute Moderate-to-Severe Pain in Adults

     Genta : Genta to Support Initiation of New Clinical Trial using Ganite® as Treatment for Life-Threatening Infections in Patients with Cystic Fibrosis

     ET Water : SmartWorks Replacement Panel for Rain Bird Controllers to Simplify Upgrades to Intelligent Irrigation Management

     ET Water : ET Water Unveils Quickdraw Remote Control Feature for Commercial Irrigation Systems

     NuVision : CR Talks To... David Hester : Privileged Partnerships

     NuVision : Top HDTVs of 2009

     Promia : U.S. Navy Annual Performance Assessment

     NuVision : Home Toys Reviews NuVision's Latest

     Promia : Promia OWLTM Managed Security Monitoring

     NuVision : Review: NuVision’s Latest Lucidium LCD Screens

     Promia : U.S. Navy Upgrading Promia Raven Units

     NuVision : NuVision crashes the projector party with LED-lamp P2, 3-chip P3

     NuVision : NuVision NVU42FX5 LCD HDTV Reviewed

     NuVision : FrontRunners: Vision Quest

     Promia : Protecting U.S. Navy Networks at Sea

     Genta : Publication Confirms Critical Link of LDH Biomarker in Genasense® Trials to Overall Survival in Advanced Melanoma

     NuVision : TechLime Raves About NuVision's New Product Lines

     Genta : Genta Raises $10 Million in Offering Stock and Notes

     NuVision : Gurus2Go for NuVision Owners

     NuVision : Flat-Panels And Profit

     Promia : NuVision focusing on LCD televisions

     Javelin Pharmaceutical : DylojectTM Well-Tolerated in High-Risk Patients

     NuVision : Cat Trail Capital Takes 99% Stake in NuVision

     NuVision : NuVision FX5

     NuVision : Twitter NuVision FX5

     NuVision : KUHVET Praises NuVision's FX5

     Genta : AGENDA Trial Passes Futility and Safety Analysis

     NuVision : NuVision FX5 LCD TVs Go Highbrow

     Genta : Genta Updates Late-Stage Progress of its Phase 3 Trial of Genasense® in Advanced Melanoma

     NuVision : Revitalized brand hits the market with an array of all-new products, a new management team and a triple-A rating

     Genta : Genta Announces Allowance of Two Key European Patents for Genasense®

     NuVision : NuVision to release latest line of high-end LCD HDTV's with Lucidium FX5 Series

     Genta : Genta Announces Completion of Patient Enrollment into Global Phase 3 Trial of Genasense® in Advanced Melanoma

     Genta : Genta Secures Up to $12 Million in Convertible Debt Financing

     ET Water : ET Water Selected by Santa Clara Valley Transportation Authority

     Genta : Study of Tesetaxel in Patients with Advanced Gastric Cancer to FDA for Special Protocol Assessment

     Javelin Pharmaceutical : Javelin Signs $71 million European Commercialization Partnership

     Genta : Genta Initiates New Clinical Trial of Tesetaxel

     Genta : Two Key U.S. Patents for its Gallium Products Franchise

     NuVision : CE Pro High-Impact Products for 2008 Features NuVision